drugset / Trial / NCT04983160

Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial

NCT04983160

RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effect of inhibiting xanthine oxidase with allopurinol in patients with chronic kidney disease in asymptomatic hyperuricemia endothelial injury and vascular repair mechanisms.

Timeline

Start
2014-02-26
Primary completion
2016-04-29
Completion
2016-04-29

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule